Koo SH

References (6)

Title : LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver - Kim_2025_Adv.Mater__e06373
Author(s) : Kim S , Kim Y , Paudel S , Kang IY , Kim J , Park S , Koo SH , Kim HS , Jun DW , Park J , Lee H , Lee J
Ref : Adv Mater , :e06373 , 2025
Abstract :
PubMedSearch : Kim_2025_Adv.Mater__e06373
PubMedID: 41045103

Title : LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver - Kim_2025_Adv.Mater__e06373
Author(s) : Kim S , Kim Y , Paudel S , Kang IY , Kim J , Park S , Koo SH , Kim HS , Jun DW , Park J , Lee H , Lee J
Ref : Adv Mater , :e06373 , 2025
Abstract :
PubMedSearch : Kim_2025_Adv.Mater__e06373
PubMedID: 41045103

Title : LDI, A Lipid Droplet Inhibitor, Disrupts Lipid Accumulation and Modulates Hepatic Lipid Profiles in Fatty Liver - Kim_2025_Adv.Mater__e06373
Author(s) : Kim S , Kim Y , Paudel S , Kang IY , Kim J , Park S , Koo SH , Kim HS , Jun DW , Park J , Lee H , Lee J
Ref : Adv Mater , :e06373 , 2025
Abstract :
PubMedSearch : Kim_2025_Adv.Mater__e06373
PubMedID: 41045103

Title : A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial - Kim_2022_Trials_23_813
Author(s) : Kim KW , Wang Q , Koo SH , Shin BS
Ref : Trials , 23 :813 , 2022
Abstract :
PubMedSearch : Kim_2022_Trials_23_813
PubMedID: 36167553

Title : A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial - Kim_2022_Trials_23_813
Author(s) : Kim KW , Wang Q , Koo SH , Shin BS
Ref : Trials , 23 :813 , 2022
Abstract :
PubMedSearch : Kim_2022_Trials_23_813
PubMedID: 36167553

Title : A single-center, randomized, parallel design study to evaluate the efficacy of donepezil in improving visuospatial abilities in patients with mild cognitive impairment using eye-tracker: the COG-EYE study protocol for a phase II trial - Kim_2022_Trials_23_813
Author(s) : Kim KW , Wang Q , Koo SH , Shin BS
Ref : Trials , 23 :813 , 2022
Abstract :
PubMedSearch : Kim_2022_Trials_23_813
PubMedID: 36167553